RIDGEFIELD - More than 35 million adults in the U.S. have chronic kidney disease .
However, as many as 90% of them are unaware of their condition. This is despite clinical guidelines, which show that.
More than 35 million adults in the U.S. have chronic kidney disease (CKD). However, as many as 90% of them are unaware of their condition. This is despite clinical guidelines, which show that using two tests can help detect it. That's why Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY) today announced the .
Hip-Hop Classic It Takes Two Takes on New Meaning in Remix to Elevate Importance of Testing for Kidney Disease lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The U.S. Food and Drug Administration (FDA) has approved Jardiance® (empagliflozin) 10 mg tablets to reduce the risk of sustained decline in.
Lawmakers are debating whether to simply cap how much people pay for insulin or to tackle the root issues that have driven up the cost of medicine. Addressing the problem is critical. More than 7 million American need insulin daily and paying for it is eating up a greater share of their household income than ever before.